Use of historical control data for assessing treatment effects in clinical trials

Author:

Viele Kert1,Berry Scott1,Neuenschwander Beat2,Amzal Billy3,Chen Fang4,Enas Nathan5,Hobbs Brian6,Ibrahim Joseph G.7,Kinnersley Nelson8,Lindborg Stacy9,Micallef Sandrine10,Roychoudhury Satrajit11,Thompson Laura12

Affiliation:

1. Berry Consultants; Austin TX USA

2. Novartis Pharma; CIS; Basel Switzerland

3. LA-SER Analytica; London UK

4. SAS; Cary NC USA

5. Eli Lilly & Company; Indianapolis IN USA

6. MD Anderson; Houston TX USA

7. University of North Carolina; Chapel Hill NC USA

8. F. Hoffman La Roche; Welwyn Garden City Hertfordshire UK

9. Biogen IDEC; Cambridge MA USA

10. Sanofi-Aventis R&D; Paris France

11. Novartis; East Hanover NJ USA

12. US Food and Drug Administration; Rockville MD USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Reference25 articles.

1. The combination of randomized and historical controls in clinical trials;Pocock;Journal of Chronic Diseases,1976

2. Commensurate priors for incorporating historical information in clinical trials using general and generalized linear models;Hobbs;Bayesian Analysis,2012

3. Power prior distributions for regression models;Ibrahim;Statistical Science,2000

4. Summarizing historical information on controls in clinical trials;Neuenschwander;Clinical Trials,2010

Cited by 358 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3